Blood pressure evaluation among older living kidney donors

Stephen C Textor, Sandra J Taler, Timothy S. Larson, Mikel Prieto, Matthew Griffin, James Gloor, Scott Nyberg, Jorge Velosa, Thomas Schwab, Mark D Stegall

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

With more patients reaching end-stage renal disease, the demand for living kidney donation is increasing rapidly. Many potential donors are now in older age groups. The effects of increasing BP with age and the measurement criteria for hypertension in this group are not well defined. A total of 238 potential donors between 18 and 72 yr of age were prospectively studied, with a comparison of "clinic" BP values measured in the outpatient clinic with an oscillometric recorder (Dinamap; Critikon), ambulatory BP monitoring (ABPM) findings, and standardized BP values determined by nurses using American Heart Association criteria. Renal function was evaluated on the basis of iothalamate clearance (GFR) and urinary protein and microalbumin excretion. Ninety-six percent of subjects were Caucasian. All subjects exhibited normal GFR and urinary protein excretion. Three age groups were defined (group I, ≤35 yr, n = 64; group II, 36 to 49 yr, n = 109; group III, ≥50 yr, n = 65). BP increased with age, as determined with all methods. Subjects ≥50 yr of age exhibited the highest clinic readings (145 ± 2/83 ± 1 mmHg, compared with 129 ± 2/76 ± 1 mmHg for group I, P " 0.01). Awake ABPM and nurse-determined BP measurements were lower than clinic readings, including those for group III (131 ± 2/80 ± 1 mmHg, compared with 145 ± 2/83 ± 1 mmHg in the clinic, P < 0.001). With the use of systolic BP values of > 140 mmHg and/or diastolic BP values of >90 mmHg, 36.7% of subjects were initially considered hypertensive; this proportion decreased to 11% overall with awake ABPM findings (>135/85 mmHg). Measurement variability (SD in ABPM) and the effects of misclassification were greatest for donors ≥50 yr of age. Multivariate regression indicated that GFR of both donors and recipients decreased with age, but regression identified no independent effect of BP. Recipient outcomes for up to 2 yr were equally good for donor kidneys considered normotensive or hypertensive on the basis of clinic BP measurements. These data indicate that higher arterial BP with age can lead to misclassification of many older living kidney donors. Sixty-two subjects with excellent kidney function were misclassified as hypertensive with clinic oscillometric measurements alone. Detailed evaluations of ABPM findings, GFR, and urinary protein levels are warranted for Caucasian subjects with high clinic BP readings who are otherwise suitable potential donors.

Original languageEnglish (US)
Pages (from-to)2159-2167
Number of pages9
JournalJournal of the American Society of Nephrology
Volume14
Issue number8
DOIs
StatePublished - Aug 1 2003

Fingerprint

Living Donors
Ambulatory Monitoring
Tissue Donors
Blood Pressure
Kidney
Reading
Age Groups
Nurses
Iothalamic Acid
Proteins
Ambulatory Care Facilities
Chronic Kidney Failure
Hypertension

ASJC Scopus subject areas

  • Nephrology

Cite this

Blood pressure evaluation among older living kidney donors. / Textor, Stephen C; Taler, Sandra J; Larson, Timothy S.; Prieto, Mikel; Griffin, Matthew; Gloor, James; Nyberg, Scott; Velosa, Jorge; Schwab, Thomas; Stegall, Mark D.

In: Journal of the American Society of Nephrology, Vol. 14, No. 8, 01.08.2003, p. 2159-2167.

Research output: Contribution to journalArticle

Textor, Stephen C ; Taler, Sandra J ; Larson, Timothy S. ; Prieto, Mikel ; Griffin, Matthew ; Gloor, James ; Nyberg, Scott ; Velosa, Jorge ; Schwab, Thomas ; Stegall, Mark D. / Blood pressure evaluation among older living kidney donors. In: Journal of the American Society of Nephrology. 2003 ; Vol. 14, No. 8. pp. 2159-2167.
@article{f43bcd2b29ee4fdfa616732503ac70fc,
title = "Blood pressure evaluation among older living kidney donors",
abstract = "With more patients reaching end-stage renal disease, the demand for living kidney donation is increasing rapidly. Many potential donors are now in older age groups. The effects of increasing BP with age and the measurement criteria for hypertension in this group are not well defined. A total of 238 potential donors between 18 and 72 yr of age were prospectively studied, with a comparison of {"}clinic{"} BP values measured in the outpatient clinic with an oscillometric recorder (Dinamap; Critikon), ambulatory BP monitoring (ABPM) findings, and standardized BP values determined by nurses using American Heart Association criteria. Renal function was evaluated on the basis of iothalamate clearance (GFR) and urinary protein and microalbumin excretion. Ninety-six percent of subjects were Caucasian. All subjects exhibited normal GFR and urinary protein excretion. Three age groups were defined (group I, ≤35 yr, n = 64; group II, 36 to 49 yr, n = 109; group III, ≥50 yr, n = 65). BP increased with age, as determined with all methods. Subjects ≥50 yr of age exhibited the highest clinic readings (145 ± 2/83 ± 1 mmHg, compared with 129 ± 2/76 ± 1 mmHg for group I, P {"} 0.01). Awake ABPM and nurse-determined BP measurements were lower than clinic readings, including those for group III (131 ± 2/80 ± 1 mmHg, compared with 145 ± 2/83 ± 1 mmHg in the clinic, P < 0.001). With the use of systolic BP values of > 140 mmHg and/or diastolic BP values of >90 mmHg, 36.7{\%} of subjects were initially considered hypertensive; this proportion decreased to 11{\%} overall with awake ABPM findings (>135/85 mmHg). Measurement variability (SD in ABPM) and the effects of misclassification were greatest for donors ≥50 yr of age. Multivariate regression indicated that GFR of both donors and recipients decreased with age, but regression identified no independent effect of BP. Recipient outcomes for up to 2 yr were equally good for donor kidneys considered normotensive or hypertensive on the basis of clinic BP measurements. These data indicate that higher arterial BP with age can lead to misclassification of many older living kidney donors. Sixty-two subjects with excellent kidney function were misclassified as hypertensive with clinic oscillometric measurements alone. Detailed evaluations of ABPM findings, GFR, and urinary protein levels are warranted for Caucasian subjects with high clinic BP readings who are otherwise suitable potential donors.",
author = "Textor, {Stephen C} and Taler, {Sandra J} and Larson, {Timothy S.} and Mikel Prieto and Matthew Griffin and James Gloor and Scott Nyberg and Jorge Velosa and Thomas Schwab and Stegall, {Mark D}",
year = "2003",
month = "8",
day = "1",
doi = "10.1097/01.ASN.0000077346.92039.9C",
language = "English (US)",
volume = "14",
pages = "2159--2167",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "8",

}

TY - JOUR

T1 - Blood pressure evaluation among older living kidney donors

AU - Textor, Stephen C

AU - Taler, Sandra J

AU - Larson, Timothy S.

AU - Prieto, Mikel

AU - Griffin, Matthew

AU - Gloor, James

AU - Nyberg, Scott

AU - Velosa, Jorge

AU - Schwab, Thomas

AU - Stegall, Mark D

PY - 2003/8/1

Y1 - 2003/8/1

N2 - With more patients reaching end-stage renal disease, the demand for living kidney donation is increasing rapidly. Many potential donors are now in older age groups. The effects of increasing BP with age and the measurement criteria for hypertension in this group are not well defined. A total of 238 potential donors between 18 and 72 yr of age were prospectively studied, with a comparison of "clinic" BP values measured in the outpatient clinic with an oscillometric recorder (Dinamap; Critikon), ambulatory BP monitoring (ABPM) findings, and standardized BP values determined by nurses using American Heart Association criteria. Renal function was evaluated on the basis of iothalamate clearance (GFR) and urinary protein and microalbumin excretion. Ninety-six percent of subjects were Caucasian. All subjects exhibited normal GFR and urinary protein excretion. Three age groups were defined (group I, ≤35 yr, n = 64; group II, 36 to 49 yr, n = 109; group III, ≥50 yr, n = 65). BP increased with age, as determined with all methods. Subjects ≥50 yr of age exhibited the highest clinic readings (145 ± 2/83 ± 1 mmHg, compared with 129 ± 2/76 ± 1 mmHg for group I, P " 0.01). Awake ABPM and nurse-determined BP measurements were lower than clinic readings, including those for group III (131 ± 2/80 ± 1 mmHg, compared with 145 ± 2/83 ± 1 mmHg in the clinic, P < 0.001). With the use of systolic BP values of > 140 mmHg and/or diastolic BP values of >90 mmHg, 36.7% of subjects were initially considered hypertensive; this proportion decreased to 11% overall with awake ABPM findings (>135/85 mmHg). Measurement variability (SD in ABPM) and the effects of misclassification were greatest for donors ≥50 yr of age. Multivariate regression indicated that GFR of both donors and recipients decreased with age, but regression identified no independent effect of BP. Recipient outcomes for up to 2 yr were equally good for donor kidneys considered normotensive or hypertensive on the basis of clinic BP measurements. These data indicate that higher arterial BP with age can lead to misclassification of many older living kidney donors. Sixty-two subjects with excellent kidney function were misclassified as hypertensive with clinic oscillometric measurements alone. Detailed evaluations of ABPM findings, GFR, and urinary protein levels are warranted for Caucasian subjects with high clinic BP readings who are otherwise suitable potential donors.

AB - With more patients reaching end-stage renal disease, the demand for living kidney donation is increasing rapidly. Many potential donors are now in older age groups. The effects of increasing BP with age and the measurement criteria for hypertension in this group are not well defined. A total of 238 potential donors between 18 and 72 yr of age were prospectively studied, with a comparison of "clinic" BP values measured in the outpatient clinic with an oscillometric recorder (Dinamap; Critikon), ambulatory BP monitoring (ABPM) findings, and standardized BP values determined by nurses using American Heart Association criteria. Renal function was evaluated on the basis of iothalamate clearance (GFR) and urinary protein and microalbumin excretion. Ninety-six percent of subjects were Caucasian. All subjects exhibited normal GFR and urinary protein excretion. Three age groups were defined (group I, ≤35 yr, n = 64; group II, 36 to 49 yr, n = 109; group III, ≥50 yr, n = 65). BP increased with age, as determined with all methods. Subjects ≥50 yr of age exhibited the highest clinic readings (145 ± 2/83 ± 1 mmHg, compared with 129 ± 2/76 ± 1 mmHg for group I, P " 0.01). Awake ABPM and nurse-determined BP measurements were lower than clinic readings, including those for group III (131 ± 2/80 ± 1 mmHg, compared with 145 ± 2/83 ± 1 mmHg in the clinic, P < 0.001). With the use of systolic BP values of > 140 mmHg and/or diastolic BP values of >90 mmHg, 36.7% of subjects were initially considered hypertensive; this proportion decreased to 11% overall with awake ABPM findings (>135/85 mmHg). Measurement variability (SD in ABPM) and the effects of misclassification were greatest for donors ≥50 yr of age. Multivariate regression indicated that GFR of both donors and recipients decreased with age, but regression identified no independent effect of BP. Recipient outcomes for up to 2 yr were equally good for donor kidneys considered normotensive or hypertensive on the basis of clinic BP measurements. These data indicate that higher arterial BP with age can lead to misclassification of many older living kidney donors. Sixty-two subjects with excellent kidney function were misclassified as hypertensive with clinic oscillometric measurements alone. Detailed evaluations of ABPM findings, GFR, and urinary protein levels are warranted for Caucasian subjects with high clinic BP readings who are otherwise suitable potential donors.

UR - http://www.scopus.com/inward/record.url?scp=0041842614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041842614&partnerID=8YFLogxK

U2 - 10.1097/01.ASN.0000077346.92039.9C

DO - 10.1097/01.ASN.0000077346.92039.9C

M3 - Article

C2 - 12874471

AN - SCOPUS:0041842614

VL - 14

SP - 2159

EP - 2167

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 8

ER -